Veracuity blog

Veracuity

Workshop

More to explorer

How credible are the adverse drug events manufacturers receive?

October 22, 2020

Collecting adverse drug events from healthcare professionals and the public is mandatory for manufacturers. Minimum criteria apply to make such a case

Will pharmacogenomic testing become a routine part of clinical care?

September 28, 2020

Some adverse drug events are a predictable consequence of therapeutic, especially dosing failures. Idiosyncratic toxicities, on the other hand, are much less

Utilizing pharmacogenomic testing to ensure effective therapy

September 17, 2020

Some medications are administered as prodrugs that need to be metabolized in the active form by the body. An example of such

Veracuity blog

Veracuity

2021 Virtual Workshop – Innovative Approaches to Drug Safety

More to explorer

How credible are the adverse drug events manufacturers receive?

Will pharmacogenomic testing become a routine part of clinical care?

Utilizing pharmacogenomic testing to ensure effective therapy

Subscribe to our newsletter

Head Office

Company

Services

Support

Blog insights

2021 Virtual Workshop – Innovative Approaches to Drug Safety

How credible are the adverse drug events manufacturers receive?

Will pharmacogenomic testing become a routine part of clinical care?

Utilizing pharmacogenomic testing to ensure effective therapy

Ⓒ Veracuity LLC 2019 - All Rights Are Reserved